Gerinnung bei schwerer Sepsis unter besonderer Berücksichtigung der Monozyten

Die frühe Diagnose der Sepsis und der pathologischen disseminierten intravaskulären Gerinnung (PDIC) und damit auch die frühzeitige Einleitung der Therapie ist heute eine der zentralen Herausforderungen der Medizin. Die vorliegende laborchemische Arbeit beschäftigte sich mit der Erhebung von Hämosta...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Weiste, Bettina
Beteiligte: Stief, Thomas (Dr.) (BetreuerIn (Doktorarbeit))
Format: Dissertation
Sprache:Deutsch
Veröffentlicht: Philipps-Universität Marburg 2010
Medizin
Schlagworte:
Online Zugang:PDF-Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

1. Voves C, Wuillemin WA, Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation pre- dicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis. 2006; 17:445-51.


2. Lilja I, Dimberg J, Sjodahl R, Tagesson C, Gustafson-Svard C. Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach. Gut. 1994; 35:40-5.


3. Sawai T, Lampman R, Hua Y et al. Lysophosphatidylcholine alters entero- cyte monolayer permeability via a protein kinase C/Ca2+ mechanism. Pediatr Surg Int. 2002; 18:591-4.


4. White B, Schmidt M, Murphy C et al. Activated protein C inhibits lipopoly- saccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 mono- cytic cell line. Br J Haematol. 2000; 110:130-4.


5. Levi M. Activated protein C in sepsis: a critical review. Curr Opin Hematol. 2008; 15:481-6.


6. 163 Song D, Ye X, Xu H, Liu SF. Activation of endothelial intrinsic NF-kappaB pathway impairs protein C anticoagulation mechanism and promotes coagula- tion in endotoxemic mice. Blood. 2009; 114:2521-9.


7. 209 Wuillemin WA, Fijnvandraat K, Derkx BH et al. Activation of the intrinsic pathway of coagulation in children with meningococcal septic shock. Thromb Haemost. 1995; 74:1436-41.


8. Mammen EF. Antithrombin: its physiological importance and role in DIC.


9. Siegel JP. Assessing the use of activated protein C in the treatment of se- vere sepsis. N Engl J Med. 2002; 347:1030-4.


10. 207 Wiedermann CJ, Kaneider NC. A systematic review of antithrombin con- centrate use in patients with disseminated intravascular coagulation of severe sepsis. Blood Coagul Fibrinolysis. 2006; 17:521-6.


11. Warren BL, Eid A, Singer P et al. Caring for the critically ill patient. High- dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA. 2001; 286:1869-78.


12. Wright SD. CD14 and innate recognition of bacteria. J Immunol. 1995; 155:6-8.


13. Mammen EF. Clinical relevance of antithrombin deficiencies. Semin Hematol. 1995; 32:2-6; discussion 7.


14. Lasky LA, Singer MS, Yednock TA et al. Cloning of a lymphocyte homing re- ceptor reveals a lectin domain. Cell. 1989; 56:1045-55.


15. Van der Poll T, van Deventer SJ. Cytokines and anticytokines in the patho- genesis of sepsis. Infect Dis Clin North Am. 1999; 13:413-26, ix.


16. Shorr AF, Trotta RF, Alkins SA, Hanzel GS, Diehl LF. D-dimer assay pre- dicts mortality in critically ill patients without disseminated intravascular coagu- lation or venous thromboembolic disease. Intensive Care Med. 1999; 25:207- 10.


17. Vervloet MG, Thijs LG, Hack CE. Derangements of coagulation and fibri- nolysis in critically ill patients with sepsis and septic shock. Semin Thromb He- most. 1998; 24:33-44.


18. Weber C, Belge KU, von Hundelshausen P et al. Differential chemokine re- ceptor expression and function in human monocyte subpopulations. J Leukoc Biol. 2000; 67:699-704.


19. 108 Mangan DF, Wahl SM. Differential regulation of human monocyte pro- grammed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol. 1991; 147:3408-12.


20. Levi M, de Jonge E, van der Poll T, ten Cate H. Disseminated intravascular coagulation. Thromb Haemost. 1999; 82:695-705.


21. 186 Trent MS, Stead CM, Tran AX, Hankins JV. Diversity of endotoxin and its impact on pathogenesis. J Endotoxin Res. 2006; 12:205-23.


22. Van Hinsberg VW, Sprengers ED, Kooistra T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin mi- crovascular endothelial cells. Thromb Haemost. 1987; 57:148-53.


23. Yan S, Chai H, Wang H et al. Effects of lysophosphatidylcholine on monolayer cell permeability of human coronary artery endothelial cells. Surgery. 2005; 138:464-73.


24. Wada H, Nakase T, Nakaya R et al. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hematol. 1994; 45:232-6.


25. Spertini O, Schleiffenbaum B, White-Owen C, Ruiz PJ, Tedder TF. ELISA for quantitation of L-selectin shed from leukocytes in vivo. J Immunol Methods. 1992; 156:115-23.


26. Waldner H, Vollmar B, Conzen P et al. Enzymfreisetzung und Aktivierung der Kallikrein-Kinin-Systeme bei experimenteller Pankreatitis. Untersuchungen in Pfortaderblut, Pankreaslymphe und Peritonealexsudat. Langenbecks Arch Chir. 1993; 378:154-9.


27. Soejima H, Ogawa H, Yasue H et al. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable an- gina. Circulation. 1999; 99:2908-13.


28. Wada H, Minamikawa K, Wakita Y et al. Hemostatic study before onset of disseminated intravascular coagulation. Am J Hematol. 1993; 43:190-4.


29. Tedder TF, Matsuyama T, Rothstein D, Schlossman SF, Morimoto C. Hu- man antigen-specific memory T cells express the homing receptor (LAM-1) necessary for lymphocyte recirculation. Eur J Immunol. 1990; 20:1351-5.


30. Liu K, Victora GD, Schwickert TA et al. In vivo analysis of dendritic cell de- velopment and homeostasis. Science. 2009; 324:392-7.


31. 181 Tedder TF, Isaacs CM, Ernst TJ, Demetri GD, Adler DA, Disteche CM. Isolation and chromosomal localization of cDNAs encoding a novel human lym- phocyte cell surface molecule, LAM-1. Homology with the mouse lymphocyte homing receptor and other human adhesion proteins. J Exp Med. 1989; 170:123-33.


32. Levi M. Keep in contact: the role of the contact system in infection and sep- sis. Crit Care Med. 2000; 28:3765-6.


33. 109 Mangan DF, Welch GR, Wahl SM. Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in hu- man peripheral blood monocytes. J Immunol. 1991; 146:1541-6.


34. Touqui L, Alaoui-El-Azher M. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr Mol Med. 2001; 1:739-54.


35. Vallet B. Microthrombosis in sepsis. Minerva Anestesiol. 2001; 67:298-301.


36. Siegelman MH, van de Rijn M, Weissman IL. Mouse lymph node homing receptor cDNA clone encodes a glycoprotein revealing tandem interaction do- mains. Science. 1989; 243:1165-72.


37. Wang JE, Jorgensen PF, Almlof M et al. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor alpha, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect Immun. 2000; 68:3965-70.


38. 195 Vary TC, Kimball SR. Regulation of hepatic protein synthesis in chronic in- flammation and sepsis. Am J Physiol. 1992; 262:C445-52.


39. 110 Martich GD, Boujoukos AJ, Suffredini AF. Response of man to endotoxin. Immunobiology. 1993; 187:403-16.


40. Warren HS, Suffredini AF, Eichacker PQ, Munford RS. Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med. 2002; 347:1027-30.


41. Mackman N. Role of tissue factor in hemostasis and thrombosis. Blood Cells Mol Dis. 2006; 36:104-7.


42. Schuster HP; Eisele B; Keinecke HO. S-antithrombin III study: antithrombin III in patients with sepsis. Intensive Care Med. 1998:Suppl 1: 76.


43. Tsiotou AG, Sakorafas GH, Anagnostopoulos G, Bramis J. Septic shock; current pathogenetic concepts from a clinical perspective. Med Sci Monit. 2005; 11:RA76-85.


44. Vadas P, Scott K, Smith G et al. Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Life Sci. 1992; 50:807-11.


45. Yang RB, Mark MR, Gurney AL, Godowski PJ. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2. J Immunol. 1999; 163:639-43.


46. 180 Taylor FBJ, Stearns-Kurosawa DJ, Kurosawa S et al. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood. 2000; 95:1680-6.


47. Ziegler-Heitbrock HW, Fingerle G, Strobel M et al. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. ; 1993.


48. Turk B, Brieditis I, Bock SC, Olson ST, Bjork I. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conforma- tional change. Biochemistry. 1997; 36:6682-91.


49. Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta. 2006; 1761:1246-59.


50. 156 Schwartz ML, Pizzo SV, Hill RL, McKee PA. The subunit structures of hu- man plasma and platelet factor XIII (fibrin-stabilizing factor). J Biol Chem. 1971; 246:5851-4.


51. Cate H. Thrombocytopenia: one of the markers of disseminated in- travascular coagulation. Pathophysiol Haemost Thromb. 2003; 33:413-6.


52. Lorente JA, Garcia-Frade LJ, Landin L et al. Time course of hemostatic ab- normalities in sepsis and its relation to outcome. Chest. 1993; 103:1536-42.


53. 161 Smith D, Gilbert M, Owen WG. Tissue plasminogen activator release in vivo in response to vasoactive agents. Blood. 1985; 66:835-9.


54. Varol C, Landsman L, Fogg DK et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med. 2007; 204:171-80.


55. 153 Schleiffenbaum B, Spertini O, Tedder TF. Soluble L-selectin is present in human plasma at high levels and retains functional activity. J Cell Biol. 1992; 119:229-38.


56. Ten Cate H, Bauer KA, Levi M et al. The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest. 1993; 92:1207-12.


57. Levi M, ten Cate H, Bauer KA et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest. 1994; 93:114-20.


58. 197 Visintin A, Mazzoni A, Spitzer JA, Segal DM. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll- like receptor 4. Proc Natl Acad Sci U S A. 2001; 98:12156-61.


59. 154 Schmaier AH, Rojkjaer R, Shariat-Madar Z. Activation of the plasma kallik- rein/kinin system on cells: a revised hypothesis. Thromb Haemost. 1999; 82:226-33.


60. 157 Seidelin JB, Nielsen OH, Strom J. Soluble L-selectin levels predict survival in sepsis. Intensive Care Med. 2002; 28:1613-8.